The Virginia Senate has approved House Bill 1989, a measure updating medical marijuana product labeling requirements and expanding delivery options for registered patients.
The bill passed the Senate today in a 30 to 10 vote. Given it was amended slightly in the Senate, the measure will now return to the House of Delegates for a final concurrence vote before heading to the governor’s desk.
Sponsored by Delegate Alex Askew (D), the legislation updates labeling rules for medical marijuana products, requiring pharmaceutical processors to provide clearer cannabinoid content information. Specifically, labels would need to display:
- The total milligrams of tetrahydrocannabinol (THC) and cannabidiol (CBD) in edible and topical cannabis products.
- The milligrams of THC and CBD per serving for these product types.
- The total percentage of THC and CBD in inhalable cannabis products.
Existing regulations mandate labels to include the total percentage and milligrams of THC and CBD in a product, along with the cannabinoid content per serving.
Additionally, HB 1989 allows pharmaceutical processors and cannabis dispensing facilities to deliver medical marijuana products to patients, registered agents, parents, or legal guardians at private residences or businesses. However, deliveries to public gathering places would remain prohibited.
While Governor Glenn Youngkin has previously opposed marijuana-related measures, it remains unclear whether he will veto the bill. However, with strong bipartisan support in both chambers, the legislation has enough backing to override a potential veto.
